Hospital ward antibiotic prescribing and the risks of Clostridium difficile infection

JAMA Internal Medicine

Volumn 175, Issue 4, 2015, Pages 626-633

  Brown, Kevin ^a   Valenta, Kim ^b   Fisman, David ^a   Simor, Andrew ^a   Daneman, Nick ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT;

ADULT; AGE; AGED; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL TRANSMISSION; CLOSTRIDIUM DIFFICILE INFECTION; COHORT ANALYSIS; DRUG EXPOSURE; DRUG USE; FEEDING APPARATUS; FEMALE; HAND WASHING; HOSPITAL INFECTION; HOSPITAL READMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PATIENT RISK; PRESCRIPTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; WARD; CANADA; CLINICAL PRACTICE; CLOSTRIDIUM INFECTIONS; COMORBIDITY; CROSS INFECTION; DIARRHEA; DRUG ADMINISTRATION; HOSPITAL PATIENT; HOSPITALIZATION; INCIDENCE; MIDDLE AGED; PEPTOCLOSTRIDIUM DIFFICILE; RISK ASSESSMENT; STATISTICS AND NUMERICAL DATA; TEACHING HOSPITAL; VERY ELDERLY;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; COMORBIDITY; CROSS INFECTION; DIARRHEA; DRUG ADMINISTRATION SCHEDULE; DRUG PRESCRIPTIONS; FEMALE; HOSPITALIZATION; HOSPITALS, TEACHING; HUMANS; INCIDENCE; INPATIENTS; MALE; MIDDLE AGED; ONTARIO; PHYSICIAN'S PRACTICE PATTERNS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS;

EID: 84928188666     PISSN: 21686106     EISSN: 21686114     Source Type: Journal    
DOI: 10.1001/jamainternmed.2014.8273     Document Type: Article

References (28)

1. Owens RC Jr, Donskey CJ, Gaynes RP, Loo VG, Muto CA. Antimicrobial-associated risk factors for Clostridium difficile infection. Clin Infect Dis. 2008;46(suppl 1):S19-S31.
2. Stevens V, Dumyati G, Fine LS, Fisher SG, van Wijngaarden E. Cumulative antibiotic exposures over time and the risk of Clostridium difficile infection. Clin Infect Dis. 2011;53(1):42-48.
3. Slimings C, Riley TV. Antibiotics and hospital-acquired Clostridium difficile infection: update of systematic review and meta-analysis. J Antimicrob Chemother. 2014;69(4):881-891.
4. Brown KA, Khanafer N, Daneman N, Fisman DN. Meta-analysis of antibiotics and the risk of community-associated Clostridium difficile infection. Antimicrob Agents Chemother. 2013;57(5):2326-2332.
5. Baxter R, Ray GT, Fireman BH. Case-control study of antibiotic use and subsequent Clostridium difficile-associated diarrhea in hospitalized patients. Infect Control Hosp Epidemiol. 2008;29(1):44-50.
6. Sethi AK, Al-Nassir WN, Nerandzic MM, Bobulsky GS, Donskey CJ. Persistence of skin contamination and environmental shedding of Clostridium difficile during and after treatment of C. difficile infection. Infect Control Hosp Epidemiol. 2010;31(1):21-27.
7. Dubberke ER, Reske KA, Olsen MA, et al. Evaluation of Clostridium difficile-associated disease pressure as a risk factor for C difficile-associated disease. Arch Intern Med. 2007;167(10):1092-1097.
8. Eyre DW, Cule ML, Wilson DJ, et al. Diverse sources of C. difficile infection identified on whole-genome sequencing. N Engl J Med. 2013;369(13):1195-1205.
9. Riggs MM, Sethi AK, Zabarsky TF, Eckstein EC, Jump RLP, Donskey CJ. Asymptomatic carriers are a potential source for transmission of epidemic and nonepidemic Clostridium difficile strains among long-term care facility residents. Clin Infect Dis. 2007;45(8):992-998.
10. Guerrero DM, Becker JC, Eckstein EC, et al. Asymptomatic carriage of toxigenic Clostridium difficile by hospitalized patients. J Hosp Infect. 2013;85(2):155-158.
11. Pakyz AL, Jawahar R, Wang Q, Harpe SE. Medication risk factors associated with healthcare-associated Clostridium difficile infection: a multilevel model case-control study among 64 US academic medical centres. J Antimicrob Chemother. 2014;69(4):1127-1131.
12. Diez Roux AV, Aiello AE. Multilevel analysis of infectious diseases. J Infect Dis. 2005;191(suppl 1):S25-S33.
13. Provincial Infectious Diseases Advisory Committee. Best Practices Document for the Management of Clostridium difficile in All Health Care Settings Protecting Patients and Staff. Toronto, ON: Ministry of Health and Long-Term Care; 2007.
14. McDonald LC, Coignard B, Dubberke E, Song X, Horan T, Kutty PK; Ad Hoc Clostridium difficile Surveillance Working Group. Recommendations for surveillance of Clostridium difficile-associated disease. Infect Control Hosp Epidemiol. 2007;28(2):140-145.
15. Zar FA, Bakkanagari SR, Moorthi KMLST, Davis MB. A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity. Clin Infect Dis. 2007;45(3):302-307.
16. WHO Collaborating Centre for Drug Statistics Methodology, Norwegian Institute of Public Health. Guidelines for ATC classification and DDD assignment 2014. Oslo, Norway: WHO Collaborating Centre for Drug Statistics Methodology, Norwegian Institute of Public Health; 2013. http://www.whocc.no/atc-ddd-publications/guidelines/. Accessed June 5, 2014.
17. Sax H, Allegranzi B, Chraïti M-N, Boyce J, Larson E, Pittet D. The World Health Organization hand hygiene observationmethod. Am J Infect Control. 2009;37(10):827-834.
18. IntHout J, Ioannidis JP, Borm GF. The Hartung-Knapp-Sidik-Jonkman method for random effectsmeta-analysis is straightforward and considerably outperforms the standard DerSimonian-Laird method. BMC Med Res Methodol. 2014;14(1):25.
19. Peduzzi P, Concato J, Feinstein AR, Holford TR. Importance of events per independent variable in proportional hazards regression analysis, II: accuracy and precision of regression estimates. J Clin Epidemiol. 1995;48(12):1503-1510.
20. Bignardi GE. Risk factors for Clostridium difficile infection. J Hosp Infect. 1998;40(1):1-15.
21. Brown KA, Fisman DN, Daneman N. Hospital Clostridium difficile infection testing rates: is "don't ask, don't tell" at play? Infect Control Hosp Epidemiol. 2014;35(7):911-912.
22. Crabtree SJ, Robertson JL, Chung KK, et al. Clostridium difficile infections in patients with severe burns. Burns. 2011;37(1):42-48.
23. nd ed. New York, NY: Oxford University Press; 2002.
24. Vynnycky E. An Introduction to Infectious Disease Modelling. New York, NY: Oxford University Press; 2010.
25. Halloran ME, Longini IM Jr, Struchiner CJ. Design and interpretation of vaccine field studies. Epidemiol Rev. 1999;21(1):73-88.
26. Feazel LM, Malhotra A, Perencevich EN, Kaboli P, Diekema DJ, Schweizer ML. Effect of antibiotic stewardship programmes on Clostridium difficile incidence: a systematic review and meta-analysis. J Antimicrob Chemother. 2014;69(7):1748-1754.
27. Dellit TH, Owens RC, McGowan JE Jr, et al Infectious Diseases Society of America; Society for Healthcare Epidemiology of America. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis. 2007;44(2):159-177.
28. Schumacher M, Allignol A, Beyersmann J, Binder N, Wolkewitz M. Hospital-acquired infections: appropriate statistical treatment is urgently needed! Int J Epidemiol. 2013;42(5):1502-1508.